In cultured cells, anthracyclines like doxorubicin and daunorubicin bind to DNA and inhibit HIF-1 and HIF-2 binding as well as the angiogenic growth factors expression, which interferes with tumor vascularization and growth (Figure 5) [104]. This evidence concerns the gene HIF1A and neoplasm.